US health regulators are expected to authorise a booster shot of Pfizer/BioNTech's Covid-19 vaccine for children aged 5 to 11 as soon as Tuesday, the New York Times reported on Monday, citing people familiar with the matter.

The companies submitted an application to the US Food and Drug Administration for this authorisation last month...